Follow the latest coverage, related explainers and connected technology stories.
CDRH has launched a reference portal explaining regulatory reliance programs for assessments and decisions by other regulatory authorities, focusing on using FDA data without transferring decision-making responsibility or reducing safety requirements. The portal provides guidance on verifying the identity of devices and their manufacturing sites and monitoring post-market safety.
The FDA explains the Small Business Determination program mechanism for companies seeking to reduce or waive medical device application fees, with different financial thresholds, documents, and deadlines depending on the type of benefit. Applications must be submitted electronically through the User Fee System and CDRH Portal, and status must be renewed each fiscal year.
The FDA’s Center for Devices and Radiological Health has issued a proposed list of medical device accessories that may be eligible for independent classification as Class I devices and opened a comment period through October 16, 2026. The action does not mean that the classification has already been approved; rather, it aims to identify accessories for which general controls are sufficient to provide reasonable assurance of safety and effectiveness.